Cargando…
Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation
Cyclin D1 (CCND1), a crucial mediator of cell cycle progression, possesses many mutation types with different mutation frequencies in human cancers. The G870A mutation is the most common mutation in CCND1, which produces two isoforms: full-length CCND1a and divergent C-terminal CCND1b. The dysregula...
Autores principales: | Wang, Jing, Su, Wei, Zhang, Taotao, Zhang, Shasha, Lei, Huiwen, Ma, Fengdie, Shi, Maoning, Shi, Wenjing, Xie, Xiaodong, Di, Cuixia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079974/ https://www.ncbi.nlm.nih.gov/pubmed/37024471 http://dx.doi.org/10.1038/s41419-023-05763-7 |
Ejemplares similares
-
Influence of cyclin D1 splicing variants expression on breast cancer chemoresistance via CDK4/CyclinD1‐pRB‐E2F1 pathway
por: Wang, Jing, et al.
Publicado: (2023) -
Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation
por: Dou, Zhihui, et al.
Publicado: (2021) -
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
por: Chen, Xiaohua, et al.
Publicado: (2022) -
Single-cell RNA sequencing reveals the transcriptomic characteristics of peripheral blood mononuclear cells in hepatitis B vaccine non-responders
por: Zhao, Meie, et al.
Publicado: (2023) -
Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development
por: Li, Shan, et al.
Publicado: (2023)